Tecan Group

TECN.SW Small Cap

Healthcare · Medical Instruments & Supplies

Updated: Apr 5, 2026, 17:43 UTC

CHF 135.40

-1.02% today

52W: CHF 110.60 – CHF 177.50

52W Low: CHF 110.60 Position: 37.1% 52W High: CHF 177.50

🔗 Compare Brokers

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

15.47x

Forward Price/Earnings

P/S Ratio

1.94x

Price-to-Sales

EV/EBITDA

19.83x

Enterprise Value/EBITDA

Div. Yield

222%

Annual dividend yield

Market Cap

$1.7B

Market Capitalization

Revenue Growth

-5.2%

YoY Revenue Growth

Profit Margin

-12.54%

Net profit margin

ROE

-8.55%

Return on Equity

Beta

1.11

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

67,469

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

8 analysts

Avg. Price Target

CHF 167.10

+23.41% upside

Target Range

CHF 137.00 – CHF 205.00

About the Company

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

Sector: Healthcare Industry: Medical Instruments & Supplies Country: Switzerland Employees: 3,026 Exchange: EBS